Wyeth ( WYE) on Friday said Bernard Poussot, president and vice chairman, would add the title of chief operating officer and also become a director.

Poussot, 55, remains in charge of Wyeth's prescription drug, consumer products, animal health and R&D units. He is the 13th member of Wyeth's board.

He joined Wyeth in 1986, and he was named president and vice chairman in April, assuming the president's title from Robert Essner, who is chairman and CEO.

The other vice chairman is Kenneth Martin, who also received the title in April. Martin, a Wyeth employee since 1984, is chief financial officer and is in charge of information services and global business operations.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says